Skip to main content

Table 3 Assigned treatment doses received and corticosteroid administration from day 0 to day 7

From: Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

  UC-MSCs (n = 21) Placebo (n = 24)
Number of doses received over 7 days 2.7 (0.6) 2.7 (0.5)
 One 2 (9.5%) 1 (4.2%)
 Two 2 (9.5%) 4 (16.7%)
 Three 17 (81%) 19 (79.2%)
Corticosteroids administered for 7 days 15 (71.4%) 19 (79.2%)
  1. Values are expressed as number (%)
  2. UC-MSCs umbilical cord-derived mesenchymal stromal cells